Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118435) titled 'A Randomized Controlled Double-Blind Trial of Liposomal Bupivacaine Local Infiltration for Pain Control After Hemorrhoidectomy' on Feb. 5.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Peking University Shenzhen Hospital
Condition:
Hemorrhoids
Intervention:
Bupivacaine Liposome Hydrochloride Bupivacaine Combination Group:LB 266mg mixed with 75mg of bupivacaine hydrochloride solution, total 30ml
Recruitment Status: Not Recruiting
Phase: 1
Date of First Enrollment: 2026-02-08
Target Sample Size: Bupivacaine Liposome Hydrochloride Bupivacaine Combination Group:90;Control grou...